Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

A novel method for analysis of human T cell repertoires by real-time PCR.

Wettstein PJ, Borson ND, Kay NE.

J Immunol Methods. 2014 Oct;412:24-34. doi: 10.1016/j.jim.2014.06.013. Epub 2014 Jun 28.

2.

Short communication: CD4 T cell declines occurring during suppressive antiretroviral therapy reflect continued production of Casp8p41.

Cummins NW, Neuhaus J, Sainski AM, Strausbauch MA, Wettstein PJ, Lewin SR, Plana M, Rizza SA, Temesgen Z, Touloumi G, Freiberg M, Neaton J, Badley AD; INSIGHT SMART Study Group.

AIDS Res Hum Retroviruses. 2014 May;30(5):476-9. doi: 10.1089/AID.2013.0243. Epub 2014 Feb 14.

3.

In utero transplanted human hepatocytes allow postnatal engraftment of human hepatocytes in pigs.

Fisher JE, Lillegard JB, McKenzie TJ, Rodysill BR, Wettstein PJ, Nyberg SL.

Liver Transpl. 2013 Mar;19(3):328-35. doi: 10.1002/lt.23598.

4.

The anticancer drug Dp44mT inhibits T-cell activation and CD25 through a copper-dependent mechanism.

Gundelach JH, Madhavan AA, Wettstein PJ, Bram RJ.

FASEB J. 2013 Feb;27(2):782-92. doi: 10.1096/fj.12-215756. Epub 2012 Nov 7.

PMID:
23134680
5.

A profile of immune response to herpesvirus is associated with radiographic joint damage in rheumatoid arthritis.

Davis JM 3rd, Knutson KL, Skinner JA, Strausbauch MA, Crowson CS, Therneau TM, Wettstein PJ, Matteson EL, Gabriel SE.

Arthritis Res Ther. 2012 Jan 31;14(1):R24. doi: 10.1186/ar3706.

6.

Does lung ischemia and reperfusion have an impact on coronary flow? A quantitative coronary blood-flow analysis with inflammatory cytokine profile.

Karapanos NT, Wettstein PJ, Li Z, Huebner M, Park SJ, Deschamps C, Cassivi SD.

Eur J Cardiothorac Surg. 2012 Jan;41(1):154-61. doi: 10.1016/j.ejcts.2011.03.053.

7.

Assessing immune function by profiling cytokine release from stimulated blood leukocytes and the risk of infection in rheumatoid arthritis.

Krause ML, Davis JM 3rd, Knutson KL, Strausbauch MA, Crowson CS, Therneau TM, Wettstein PJ, Matteson EL, Gabriel SE.

Clin Immunol. 2011 Oct;141(1):67-72. doi: 10.1016/j.clim.2011.05.008. Epub 2011 May 30. Erratum in: Clin Immunol. 2011 Dec;141(3):372. Strausbach, Michael A [corrected to Strausbauch, Michael A].

8.

MHC class II epitope nesting modulates dendritic cell function and improves generation of antigen-specific CD4 helper T cells.

Erskine CL, Krco CJ, Hedin KE, Borson ND, Kalli KR, Behrens MD, Heman-Ackah SM, von Hofe E, Wettstein PJ, Mohamadzadeh M, Knutson KL.

J Immunol. 2011 Jul 1;187(1):316-24. doi: 10.4049/jimmunol.1100658. Epub 2011 May 25.

9.

A signature of aberrant immune responsiveness identifies myocardial dysfunction in rheumatoid arthritis.

Davis JM 3rd, Knutson KL, Strausbauch MA, Crowson CS, Therneau TM, Wettstein PJ, Roger VL, Matteson EL, Gabriel SE.

Arthritis Rheum. 2011 Jun;63(6):1497-506. doi: 10.1002/art.30323.

10.

Analysis of complex biomarkers for human immune-mediated disorders based on cytokine responsiveness of peripheral blood cells.

Davis JM 3rd, Knutson KL, Strausbauch MA, Crowson CS, Therneau TM, Wettstein PJ, Matteson EL, Gabriel SE.

J Immunol. 2010 Jun 15;184(12):7297-304. doi: 10.4049/jimmunol.0904180. Epub 2010 May 21.

11.

A degenerate HLA-DR epitope pool of HER-2/neu reveals a novel in vivo immunodominant epitope, HER-2/neu88-102.

Karyampudi L, Formicola C, Erskine CL, Maurer MJ, Ingle JN, Krco CJ, Wettstein PJ, Kalli KR, Fikes JD, Beebe M, Hartmann LC, Disis ML, Ferrone S, Ishioka G, Knutson KL.

Clin Cancer Res. 2010 Feb 1;16(3):825-34. doi: 10.1158/1078-0432.CCR-09-2781. Epub 2010 Jan 26.

12.

Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigen.

Karyampudi L, Krco CJ, Kalli KR, Erskine CL, Hartmann LC, Goodman K, Ingle JN, Maurer MJ, Nassar A, Yu C, Disis ML, Wettstein PJ, Fikes JD, Beebe M, Ishioka G, Knutson KL.

Cancer Immunol Immunother. 2010 Jan;59(1):161-71. doi: 10.1007/s00262-009-0738-z. Epub 2009 Jul 21.

13.

Beneficial effect of TRAIL on HIV burden, without detectable immune consequences.

Shepard BD, De Forni D, McNamara DR, Foli A, Rizza SA, Abraham RS, Knutson K, Wettstein PJ, Lori F, Badley AD.

PLoS One. 2008 Aug 28;3(8):e3096. doi: 10.1371/journal.pone.0003096.

14.

Biologic properties and enucleation of red blood cells from human embryonic stem cells.

Lu SJ, Feng Q, Park JS, Vida L, Lee BS, Strausbauch M, Wettstein PJ, Honig GR, Lanza R.

Blood. 2008 Dec 1;112(12):4475-84. doi: 10.1182/blood-2008-05-157198. Epub 2008 Aug 19.

15.

An HLA-DR-degenerate epitope pool detects insulin-like growth factor binding protein 2-specific immunity in patients with cancer.

Kalli KR, Krco CJ, Hartmann LC, Goodman K, Maurer MJ, Yu C, Johnson EM, Erskine CL, Disis ML, Wettstein PJ, Fikes JD, Beebe M, Ishioka G, Knutson KL.

Cancer Res. 2008 Jun 15;68(12):4893-901. doi: 10.1158/0008-5472.CAN-07-6726.

16.

Nelfinavir monotherapy increases naïve T-cell numbers in HIV-negative healthy young adults.

Rizza SR, Tangalos EG, McClees MD, Strausbauch MA, Targonski PV, McKean DJ, Wettstein PJ, Badley AD.

Front Biosci. 2008 Jan 1;13:1605-9.

17.
18.
19.

Fitness of cell-mediated immunity independent of repertoire diversity.

AbuAttieh M, Rebrovich M, Wettstein PJ, Vuk-Pavlovic Z, Limper AH, Platt JL, Cascalho M.

J Immunol. 2007 Mar 1;178(5):2950-60.

20.

T-cell immunity to the folate receptor alpha is prevalent in women with breast or ovarian cancer.

Knutson KL, Krco CJ, Erskine CL, Goodman K, Kelemen LE, Wettstein PJ, Low PS, Hartmann LC, Kalli KR.

J Clin Oncol. 2006 Sep 10;24(26):4254-61. Epub 2006 Aug 14.

PMID:
16908932
21.

Expression of mRNA for a newly identified Pax5 exon is reduced in multiple myeloma.

Borson ND, Lacy MQ, Wettstein PJ.

Mamm Genome. 2006 Mar;17(3):248-56. Epub 2006 Mar 3.

PMID:
16518692
22.

Cysteine-tailed class I-binding peptides bind to CpG adjuvant and enhance primary CTL responses.

Wettstein PJ, Borson ND, Park JG, McNallan KT, Reed AM.

J Immunol. 2005 Sep 15;175(6):3681-9.

23.

Long-term bovine hematopoietic engraftment with clone-derived stem cells.

Lanza R, Shieh JH, Wettstein PJ, Sweeney RW, Wu K, Weisz A, Borson N, Henderson B, West MD, Moore MA.

Cloning Stem Cells. 2005;7(2):95-106.

PMID:
15971983
24.

Aerosolized granulocyte macrophage colony-stimulating factor (GM-CSF) therapy in metastatic cancer.

Rao RD, Anderson PM, Arndt CA, Wettstein PJ, Markovic SN.

Am J Clin Oncol. 2003 Oct;26(5):493-8.

PMID:
14528078
25.

Nonhuman primate parthenogenetic stem cells.

Vrana KE, Hipp JD, Goss AM, McCool BA, Riddle DR, Walker SJ, Wettstein PJ, Studer LP, Tabar V, Cunniff K, Chapman K, Vilner L, West MD, Grant KA, Cibelli JB.

Proc Natl Acad Sci U S A. 2003 Sep 30;100 Suppl 1:11911-6. Epub 2003 Sep 22. Erratum in: Proc Natl Acad Sci U S A. 2004 Jan 13;101(2):693.

26.

Characterization of antigen processing machinery and Survivin expression in tonsillar squamous cell carcinoma.

Weinman EC, Roche PC, Kasperbauer JL, Cha SS, Sargent DJ, Cheville J, Murphy LM, Chen L, Wettstein PJ, Gostout B, Ferrone S, Strome SE.

Cancer. 2003 May 1;97(9):2203-11.

28.

Altered mRNA expression of Pax5 and Blimp-1 in B cells in multiple myeloma.

Borson ND, Lacy MQ, Wettstein PJ.

Blood. 2002 Dec 15;100(13):4629-39.

29.

Generation of histocompatible tissues using nuclear transplantation.

Lanza RP, Chung HY, Yoo JJ, Wettstein PJ, Blackwell C, Borson N, Hofmeister E, Schuch G, Soker S, Moraes CT, West MD, Atala A.

Nat Biotechnol. 2002 Jul;20(7):689-96. Epub 2002 Jun 3.

PMID:
12089553
30.

Parthenogenetic stem cells in nonhuman primates.

Cibelli JB, Grant KA, Chapman KB, Cunniff K, Worst T, Green HL, Walker SJ, Gutin PH, Vilner L, Tabar V, Dominko T, Kane J, Wettstein PJ, Lanza RP, Studer L, Vrana KE, West MD.

Science. 2002 Feb 1;295(5556):819. No abstract available.

31.

Cloned cattle can be healthy and normal.

Lanza RP, Cibelli JB, Faber D, Sweeney RW, Henderson B, Nevala W, West MD, Wettstein PJ.

Science. 2001 Nov 30;294(5548):1893-4. No abstract available.

32.

Innate resistance to Babesia infection is influenced by genetic background and gender.

Aguilar-Delfin I, Homer MJ, Wettstein PJ, Persing DH.

Infect Immun. 2001 Dec;69(12):7955-8.

33.

TAP-independent presentation of CTL epitopes by Trojan antigens.

Lu J, Wettstein PJ, Higashimoto Y, Appella E, Celis E.

J Immunol. 2001 Jun 15;166(12):7063-71.

34.

Optimizing preparation of normal dendritic cells and bcr-abl+ mature dendritic cells derived from immunomagnetically purified CD14+ cells.

Dietz AB, Bulur PA, Erickson MR, Wettstein PJ, Litzow MR, Wyatt WA, Dewald GW, Tefferi A, Pankratz VS, Vuk-Pavlović S.

J Hematother Stem Cell Res. 2000 Feb;9(1):95-101.

PMID:
10738977
35.

V(beta)8(+) T cells protect from demyelinating disease in a viral model of multiple sclerosis.

Drescher KM, Johnston SL, Hogancamp W, Nabozny GH, David CS, Rimm IJ, Wettstein PJ, Rodriguez M.

Int Immunol. 2000 Mar;12(3):271-80.

PMID:
10700462
36.

Biochemical and immunogenetic analysis of an immunodominant peptide (B6dom1) encoded by the classical H7 minor histocompatibility locus.

Eden PA, Christianson GJ, Fontaine P, Wettstein PJ, Perreault C, Roopenian DC.

J Immunol. 1999 Apr 15;162(8):4502-10.

37.

Temporal sequence of transcription of perforin, Fas ligand, and tumor necrosis factor-alpha genes in rejecting skin allografts.

Borson ND, Strausbauch MA, Kennedy RB, Oda RP, Landers JP, Wettstein PJ.

Transplantation. 1999 Mar 15;67(5):672-80.

PMID:
10096521
38.

Infrared-mediated thermocycling for ultrafast polymerase chain reaction amplification of DNA.

Oda RP, Strausbauch MA, Huhmer AF, Borson N, Jurrens SR, Craighead J, Wettstein PJ, Eckloff B, Kline B, Landers JP.

Anal Chem. 1998 Oct 15;70(20):4361-8.

PMID:
9796420
39.

Direct quantitation of RNA transcripts by competitive single-tube RT-PCR and capillary electrophoresis.

Borson ND, Strausbauch MA, Wettstein PJ, Oda RP, Johnston SL, Landers JP.

Biotechniques. 1998 Jul;25(1):130-7.

PMID:
9668987
40.

Vector-hexamer PCR isolation of all insert ends from a YAC contig of the mouse Igh locus.

Herring CD, Chevillard C, Johnston SL, Wettstein PJ, Riblet R.

Genome Res. 1998 Jun;8(6):673-81.

41.

Identification of mimotopes for the H4 minor histocompatibility antigen.

Strausbauch MA, Nevala WK, Roopenian DC, Stefanski HE, Wettstein PJ.

Int Immunol. 1998 Apr;10(4):421-34.

PMID:
9620598
42.

Capillary electrophoresis of insulin-like growth factors: enhanced ultraviolet detection using dynamically coated capillaries and on-line solid-phase extraction.

Roche ME, Anderson MA, Oda RP, Riggs BL, Strausbauch MA, Okazaki R, Wettstein PJ, Landers JP.

Anal Biochem. 1998 Apr 10;258(1):87-95.

PMID:
9527853
43.

Spectratyping of TCRs expressed by CTL-infiltrating minor histocompatibility antigen-disparate allografts.

Johnston SL, Borson ND, Wettstein PJ.

J Immunol. 1997 Dec 1;159(11):5233-45.

PMID:
9548462
44.
45.
46.

Hydrophobic peptide mapping of clinically relevant heptathelical membrane proteins by capillary electrophoresis.

Dong M, Oda RP, Strausbauch MA, Wettstein PJ, Landers JP, Miller LJ.

Electrophoresis. 1997 Sep;18(10):1767-74.

PMID:
9372268
47.

Differential effects of infection with a Babesia-like piroplasm, WA1, in inbred mice.

Moro MH, David CS, Magera JM, Wettstein PJ, Barthold SW, Persing DH.

Infect Immun. 1998 Feb;66(2):492-8.

48.

Immunodominant minor histocompatibility antigen peptides presented by H2Db molecules.

Nevala WK, Wettstein PJ.

Transplantation. 1997 Nov 15;64(9):1323-30.

PMID:
9371675
49.

T cell receptor diversity in CTLs specific for the CTT-1 and CTT-2 minor histocompatibility antigens.

Johnston SL, Wettstein PJ.

J Immunol. 1997 Sep 15;159(6):2606-15.

PMID:
9300679
50.

Supplemental Content

Loading ...
Support Center